Search

Background/Objectives: Spironolactone (SP), an aldosterone inhibitor widely used to treat androgen-dependent disorders such as acne, hirsutism, and alopecia, has demonstrated therapeutic potential in both oral and topical formulations. However, SP's low solubility and poor bioavailability in conventional formulations have driven the development of novel nanocarriers to enhance its efficacy. This review systematically examines recent advancements in SP-loaded nanocarriers, including lipid nanoparticles (LNPs), vesicular nanoparticles (VNPs), polymeric nanoparticles (PNPs), and nanofibers (NFs). Methods: A search strategy was developed, and the relevant literature was systematically searched using databases such as Scopus, PubMed, and Google Scholar. The review process, including screening, inclusion, and exclusion criteria, adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results: A comprehensive analysis of 13 eligible research articles, corresponding to 15 studies, highlights key aspects such as encapsulation efficiency, stability, particle size, and in vitro and in vivo efficacy. Six studies focused on lipid nanoparticles (LNPs), including solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), which were found to improve SP's bioavailability and skin permeation. Another six studies investigated vesicular nanoparticles (VNPs), such as ethosomes and niosomes, demonstrating superior skin targeting and penetration capabilities. Two studies on polymeric nanoparticles (PNPs) showed effectiveness in delivering SP to hair follicles for the treatment of alopecia and acne. Additionally, one study on SP-loaded nanofibers indicated significant potential for topical rosacea therapy. Conclusions: SP-loaded nanocarrier systems represent promising advancements in targeted topical therapy. However, further clinical studies are required to optimize their safety, efficacy, and delivery mechanisms. [ABSTRACT FROM AUTHOR]

The present study aimed to develop a novel temperature and pressure-controlled hybrid system (Cent-Hydro) for large-scale nanofiber production. Nanofibers from a hydrophilic carrier matrix were prepared using the Cent-Hydro system. This study explores the effect of increasing working temperature on the surface tension and viscosity of polymer solutions. The Cent-Hydro system was calibrated through the process of jet formation, and spinning parameters were identified for the jet path. The formation of fingers in front of the thin liquid occurred due to Rayleigh–Taylor instability, and a lower concentration of polymer solution favoured the development of thinner and longer fingers. The critical angular velocity and initial velocity for jet formation were obtained when the balance between surface tension, centrifugal force, and viscous force was achieved. The effect of increasing rotational speed and working temperature on finger velocity and length was experimentally evaluated, concluding that an increase in working temperature increases finger velocity and length. Additionally, the effect of increasing rotational speed, polymer concentration, and working temperature on the diameter of the nanofiber was evaluated. Overall, the Cent-Hydro system presents a compelling proposition for large-scale nanofiber production, offering distinct advantages over conventional methods and paving the way for advancements in various applications. [ABSTRACT FROM AUTHOR]

Arsenic, the 20th most common element in Earth's crust and historically regarded as the King of Poisons, occurs naturally in two oxidation states, Arsenate (V) and Arsenite (III), and is prevalent worldwide through natural and anthropogenic means. The cations of the metalloid exhibit unique chemical behaviour in water and are found to be components of approximately 245 natural minerals, making its occurrence in drinking water a compelling challenge, especially in groundwater. This comprehensive review collates information regarding the prevalence of arsenic contamination in water worldwide and its impact on human health, its chemical behaviour, methods for detection and quantification, and treatment strategies. A comprehensive search was conducted, and the selection of eligible studies was carried out using the PRISMA (the preferred reporting items for systematic reviews and meta-analyses) guidelines. Essential characteristics of eligible research studies were extracted based on geographical areas, origins, concentration levels and the magnitude of populations vulnerable to arsenic contamination in groundwater sources. Arsenic contamination of water affects over 100 countries including Canada, the United States, Pakistan, China, India, Brazil and Bangladesh, where hydrogeological conditions favour prevalence and groundwater is the primary water source for food preparation, irrigation of food crops and drinking water. This leads to human exposure through absorption, ingestion and inhalation, causing numerous health disorders affecting nearly all systems within the human body, with acute and chronic toxicity including cancers. The presence of arsenic in water poses a considerable challenge to humanity, prompting scientists to devise diverse mitigation approaches categorized as (a) oxidation processes, (b) precipitation methods, (c) membrane technologies, (d) adsorption and ion exchange methods, and (e) social interventions. This comprehensive review is expected to be a valuable source for professionals in the water industry, public management, and policymaking, aiding their ongoing and future research and development efforts. [ABSTRACT FROM AUTHOR]

Background: Oral anticoagulation (OAC) is the mainstay of treatment for the prevention of strokes in patients with atrial fibrillation (AF). Direct oral anticoagulants (DOACs) account for increasing OAC in patients with AF. However, prescribing DOACs for patients with established AF poses various challenges and general practice pharmacists may have an important role in supporting their management. Aim: To investigate the effectiveness of pharmacist-led interventions in general practice in optimising the use of OAC therapies in AF. Design & setting: A retrospective observational study in general practices in Bradford. Method: The data were collected retrospectively from 1 November 2018–31 December 2019 using electronic health record data. The data were analysed: 1) to identify patients with AF not on OAC; 2) to describe inappropriate DOAC prescriptions; and 3) to calculate HAS-BLED scores. Results: Overall, 76.3% (n = 470) of patients with AF received OAC therapy, and of these, 63.4% received DOACs. Pharmacist-led interventions increased DOAC prescribing by 6.0% (P = 0.03). Inappropriate DOAC use was identified in 24.5% of patients with AF, with underdosed and overdosed identified in 9.7% and 14.8%, respectively. Post-intervention, inappropriate prescribing was reduced to 1.7%. The mean HAS-BLED score decreased from 3.00 to 2.22 (P<0.01). Successful transition from vitamin K antagonist (VKA) therapy to DOACs was achieved in 25.7% of patients. Conclusion: Pharmacist-led interventions have successfully improved the use of OAC therapies in patients with AF, and effectively managed the bleeding risks and transition from VKA to DOAC therapy, in line with guidelines. [ABSTRACT FROM AUTHOR]